News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sorin Group S.p.A. (SRN) Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty Ring in Japan



5/16/2012 10:34:37 AM

TOKYO--(BUSINESS WIRE)--Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announces that it received authorization from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) to market its MEMO 3D Semi-Rigid Annuloplasty Ring. The first MEMO 3D implant was performed at the Kobe City Medical Center General Hospital.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES